Phio Pharmaceuticals
PHIO
#10678
Rank
C$17.34 M
Marketcap
C$1.49
Share price
-6.19%
Change (1 day)
-56.45%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -C$15.09 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$12.26 Million a decrease over its 2024 earnings that were of -C$10.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$15.09 Million23.16%
2025 -C$12.26 Million21.65%
2024 -C$10.08 Million-33.96%
2023 -C$15.25 Million-5.7%
2022 -C$16.18 Million-13.6%
2021 -C$18.72 Million51.09%
2020 -C$12.39 Million-1.28%
2019 -C$12.55 Million21.03%
2018 -C$10.37 Million-53.1%
2017 -C$22.11 Million74.49%
2016 -C$12.67 Million-12.02%
2015 -C$14.41 Million16.17%
2014 -C$12.4 Million-57.95%
2013 -C$29.48 Million62.45%
2012 -C$18.15 Million0.87%
2011 -C$17.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.33 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.58 Million 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA